Indian Vildagliptin Exporters: Complete Supplier Ranking with Market Share — 178 Manufacturers (2026) — TransData Nexus

Q: Who is the largest vildagliptin supplier from India?

AJANTA PHARMA LIMITED is the largest vildagliptin exporter from India with a 18.0% market share and export value of $1.8M.

Q: How many vildagliptin suppliers are there in India?

There are 178 active vildagliptin exporters in India, collectively shipping $10.2M worth of vildagliptin across 1,149 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top vildagliptin suppliers from India?

The top 5 vildagliptin suppliers from India — AJANTA PHARMA LIMITED, CADILA PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED, EMCURE PHARMACEUTICALS LIMITED, INNOVA CAPTAB LIMITED — together control 54.7% of total vildagliptin export value from India.

Suresh Sormare

Vildagliptin

India Pharmaceutical Trade Intelligence

$10.2M178 Suppliers87 CountriesHS 30049099

ExportsIndia → FRANCE14.4%India → PORTUGAL10.1%

ImportsTURKEY → India$2110.6B SPAIN → India$164.0B

#1 Supplier: AJANTA PHARMA #1 Buyer: PLANET PHARMA

Vildagliptin Suppliers from India (2026) — 178 Exporters, $10.2M Market | TransData Nexus | TransData Nexus

Who Exports Vildagliptin from India — 178 Suppliers Behind a $10.2M Market

India's vildagliptin export market is supplied by 178 active exporters who collectively shipped $10.2M across 1,149 shipments. AJANTA PHARMA LIMITED leads with a 18.0% market share, followed by CADILA PHARMACEUTICALS LIMITED and INTAS PHARMACEUTICALS LIMITED. The top 5 suppliers together control 54.7% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published April 2026

India's Top Vildagliptin Suppliers & Exporters — 178 manufacturers, $10.2M export market, top destinations and formulations — Vildagliptin supplier data — 178 exporters · $10.2M market · 1,149 shipmentsTransData Nexus · Indian Customs Data

Top Vildagliptin Exporters from India — Ranked by Export Value

AJANTA PHARMA LIMITED is the leading vildagliptin exporter from India, holding a 18.0% share of the $10.2M market across 1,149 shipments from 178 exporters. The top 5 suppliers — AJANTA PHARMA LIMITED, CADILA PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED, EMCURE PHARMACEUTICALS LIMITED, INNOVA CAPTAB LIMITED — collectively control 54.7% of total export value, indicating a moderately concentrated market. Individual shares are: AJANTA PHARMA LIMITED (18.0%), CADILA PHARMACEUTICALS LIMITED (10.1%), INTAS PHARMACEUTICALS LIMITED (9.8%), EMCURE PHARMACEUTICALS LIMITED (9.7%), INNOVA CAPTAB LIMITED (7.1%).

Top Vildagliptin Exporters from India

Ranked by export value · 178 active suppliers · Indian Customs (DGFT) data

Apr 2026

Top Vildagliptin Exporters from India — Ranked by Export Value. 178 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Vildagliptin exporters

Certification and compliance status for top Vildagliptin suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Intas Pharmaceuticals Limited	Warning Letter, November	Yes, April 2007	Yes	Not verified	Received FDA warning letter for CGMP violations at Sanand facility.
Emcure Pharmaceuticals Limited	Warning Letter, August 20	Yes	Yes	Not verified	Received FDA warning letter for data integrity issues at Hinjawadi plant.
Cadila Pharmaceuticals Limited	Warning Letter, October 2	Yes	Yes	Not verified	Received FDA warning letter for CGMP violations at Moraiya and Ahmedabad facilit
Ajanta Pharma Limited	Approved	Yes	Yes	Not verified	Manufacturing facilities at Dahej and Paithan approved by US FDA.
Micro Labs Limited	Approved	Yes	Yes	Not verified	Operates 14 GMP-compliant manufacturing plants in India.
Sun Pharmaceutical Industries Limited	Approved	Yes	Yes	Not verified	Multiple facilities approved by US FDA and EU authorities.
Macleods Pharmaceuticals Ltd	Approved	Yes	Yes	Not verified	Manufacturing facilities approved by US FDA and WHO.
AET Laboratories Private Limited	Approved	Yes	Yes	Not verified	Facilities comply with international regulatory standards.
Aquatic Remedies Limited	Approved	Yes	Yes	Not verified	Manufacturing units meet global regulatory requirements.
Beta Drugs Limited	Approved	Yes	Yes	Not verified	Facilities adhere to international quality standards.

TransData Nexus reviewed the regulatory standing of 10 leading Vildagliptin exporters from India. 7 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 10 are EU GMP compliant. 3 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Vildagliptin sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes approximately 40% of the country's bulk drug production. The city hosts over 2,000 pharmaceutical companies, including major players like Aurobindo Pharma and Dr. Reddy’s Laboratories. The establishment of Genome Valley, a premier biotech cluster, has further solidified Hyderabad's position as a hub for pharmaceutical research and manufacturing.

The Telangana government's initiatives, such as the Hyderabad Pharma City project, aim to create a comprehensive ecosystem for pharmaceutical manufacturing, research, and development. This integrated approach enhances the city's capacity to produce active pharmaceutical ingredients (APIs) like Vildagliptin efficiently.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is a significant center for pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports. Vadodara, in particular, is home to Alembic Pharmaceuticals, one of the oldest pharmaceutical companies in India, established in 1907.

The region's robust infrastructure and skilled workforce have attracted numerous pharmaceutical companies, making it a key area for the production of finished dosage forms, including Vildagliptin tablets. The presence of multiple USFDA-certified facilities underscores the region's compliance with international quality standards.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Vildagliptin exporters from India

June 2023

M&A

Innova Captab Limited — Innova Captab acquires Sharon Bio-Medicine Limited

In June 2023, Innova Captab Limited completed the acquisition of Sharon Bio-Medicine Limited through the Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code (IBC). The company infused ₹195.40 crore into Sharon on June 26, 2023, making it a wholly owned subsidiary of Univentis Medicare Limited, Innova Captab's direct subsidiary. - IMPACT: This acquisition is expected to enhance Innova Captab's manufacturing capabilities, potentially increasing their Vildagliptin production capacity and export volumes.

Impact: This acquisition is expected to enhance Innova Captab's manufacturing capabilities, potentially increasing their Vildagliptin production capacity and export volumes.

November 2023

Capacity Expansion

Cadila Pharmaceuticals Limited — Cadila Pharmaceuticals inaugurates new API plant in Dahej

In November 2023, Cadila Pharmaceuticals opened an active pharmaceutical ingredient (API) plant in Dahej, Gujarat's Bharuch district. The facility was built with an investment of ₹200 crore and is equipped with distributed control system (DCS) automation technology. - IMPACT: The new API plant is likely to bolster Cadila Pharmaceuticals' production capacity, potentially leading to increased Vildagliptin exports.

Common Questions — Vildagliptin Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which vildagliptin supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, AJANTA PHARMA LIMITED leads with 92 recorded shipments worth $1.8M. CADILA PHARMACEUTICALS LIMITED (22 shipments) and INTAS PHARMACEUTICALS LIMITED (53 shipments) are also established high-volume exporters.

Q How many vildagliptin manufacturers are there in India?

India has 178 active vildagliptin exporters with a combined export market of $10.2M across 1,149 shipments to 87 countries. The top 5 suppliers hold 54.7% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Vildagliptin

Vildagliptin

Who Exports Vildagliptin from India — 178 Suppliers Behind a $10.2M Market

Top Vildagliptin Exporters from India — Ranked by Export Value

Top Vildagliptin Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

Recent M&A, Collaborations & Capacity Expansions

Innova Captab Limited — Innova Captab acquires Sharon Bio-Medicine Limited

Cadila Pharmaceuticals Limited — Cadila Pharmaceuticals inaugurates new API plant in Dahej

Common Questions — Vildagliptin Suppliers from India

Q Which vildagliptin supplier from India is the most reliable for bulk orders?

Q How many vildagliptin manufacturers are there in India?

Q What certifications should I verify?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Mumbai-Thane-Raigad — Export Gateway

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Emcure Pharmaceuticals Limited — Emcure Pharmaceuticals files Draft Red Herring Prospectus for IPO

Q What is the typical price range for vildagliptin from India?

Analysis Methodology